716
Participants
Start Date
May 9, 2016
Primary Completion Date
December 22, 2020
Study Completion Date
April 9, 2024
Nivolumab
Temozolomide
Radiotherapy
Nivolumab Placebo
Local Institution - 0064, Lausanne
Local Institution - 0061, Vienna
Local Institution - 0070, Brussels
Local Institution - 0069, Brussels
Local Institution - 0065, Geneva
Local Institution - 0052, St Leonards
Local Institution - 0084, Copenhagen
Local Institution - 0049, Liverpool
Local Institution - 0071, Leuven
Local Institution - 0050, Heidelberg
Local Institution - 0051, Prahran
Local Institution - 0062, Linz
Local Institution - 0085, Odense
Local Institution - 0122, Nedlands
Local Institution - 0063, Zurich
Local Institution - 0015, New York
Local Institution - 0024, New York
Local Institution - 0091, Torino
Local Institution - 0040, Marseille
Local Institution - 0080, Santiago Compostela
Local Institution - 0098, Allentown
Local Institution - 0016, Philadelphia
Local Institution - 0031, Washington D.C.
Local Institution - 0127, Rozzano (milano)
Local Institution - 0089, Milan
Local Institution - 0057, Hamburg
Local Institution - 0020, Baltimore
Preston Robert Tisch Brain Tumor Center at Duke University, Durham
Local Institution - 0077, Madrid
Local Institution - 0076, Madrid
Local Institution - 0032, Charlotte
Local Institution - 0021, Charleston
Local Institution - 0045, Toulouse
Local Institution - 0087, Miami
Local Institution - 0030, Tampa
Local Institution - 0044, Rennes
Local Institution - 0092, Padua
Local Institution - 0008, Nashville
Erlanger Oncology & Hematology - Univ. of TN, Chattanooga
Local Institution - 0088, Bologna
Local Institution - 0018, Louisville
Local Institution - 0027, Columbus
Local Institution - 0001, Cleveland
Local Institution - 0079, Valencia
Local Institution - 0054, Münster
Local Institution - 0035, Detroit
Local Institution - 0094, Petah Tikva
Local Institution - 0131, Cologne
Local Institution - 0090, Siena
Local Institution - 0055, Bonn
Local Institution - 0042, Nancy
Local Institution - 0043, Lille
Local Institution - 0053, Frankfurt am Main
Local Institution - 0022, Chicago
Local Institution - 0002, St Louis
Local Institution - 0093, Tel Aviv
Local Institution - 0060, Westwood
Local Institution - 0056, Heidelberg
Local Institution - 0041, Lyon
Local Institution - 0059, Tübingen
Local Institution - 0038, Paris
Local Institution - 0039, Paris
Local Institution - 0124, Freiburg im Breisgau
Local Institution - 0130, Munich
Local Institution - 0009, Salt Lake City
Local Institution - 0003, Phoenix
Cedars Sinai Medical Center, Los Angeles
Local Institution - 0123, Erlangen
Local Institution - 0029, San Diego
Local Institution - 0058, Regensburg
Local Institution - 0128, Sacramento
Local Institution - 0005, Seattle
Local Institution - 0095, Moscow
Local Institution - 0097, Moscow
Local Institution - 0111, Chuo-ku
Local Institution - 0114, Bunkyo-ku
Local Institution - 0115, Shinjuku-ku
Local Institution - 0118, Sagamihara-shi
Local Institution - 0099, Chiba
Local Institution - 0116, Tsukuba
Local Institution - 0121, Hidaka-shi
Local Institution - 0110, Nagoya
Local Institution - 0112, Suita
Local Institution - 0104, Hirakata-shi
Local Institution - 0109, Kyoto
Local Institution - 0120, Okayama
Local Institution - 0100, Hiroshima
Local Institution - 0106, Kumamoto
Local Institution - 0102, Kagoshima
Local Institution - 0103, Kanazawa
Local Institution - 0117, Yamagata
Local Institution - 0023, Birmingham
Local Institution - 0010, Los Angeles
Local Institution - 0006, San Francisco
Local Institution - 0004, New Haven
Local Institution - 0011, Boston
Local Institution - 0028, Boston
Local Institution - 0017, Edison
Local Institution - 0012, Hackensack
Local Institution - 0025, Dallas
Local Institution - 0046, Vancouver
Local Institution - 0048, Toronto
Local Institution - 0047, Montreal
Local Institution - 0101, Sapporo
Local Institution - 0105, Kobe
Local Institution - 0107, Mitaka-shi
Local Institution - 0108, Kyoto
Local Institution - 0073, Rotterdam
Local Institution - 0075, Amsterdam
Local Institution - 0074, Groningen
Local Institution - 0072, Utrecht
Local Institution - 0083, Oslo
Local Institution - 0086, Gdansk
Local Institution - 0132, Warsaw
Local Institution - 0126, Badalona-barcelona
Local Institution - 0078, Barcelona
Local Institution - 0125, Barcelona
Local Institution - 0081, Lund
Local Institution - 0082, Solna
Local Institution - 0066, Manchester
Local Institution - 0119, Sutton
Local Institution - 0068, Glasgow
Local Institution - 0067, London
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY